These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 14525594

  • 21. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
    Nashan B, Light S, Hardie IR, Lin A, Johnson JR.
    Transplantation; 1999 Jan 15; 67(1):110-5. PubMed ID: 9921806
    [Abstract] [Full Text] [Related]

  • 22. Daclizumab rapidly saturates interleukin-2 receptor-alpha (CD25) on lymph node lymphocytes in children.
    Savo AM, Book BK, Henson S, Hakimi J, Pescovitz MD.
    Transplant Proc; 1999 Jan 15; 31(1-2):1182-3. PubMed ID: 10083528
    [No Abstract] [Full Text] [Related]

  • 23. Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients.
    Kreijveld E, Koenen HJ, Klasen IS, Hilbrands LB, Joosten I.
    Am J Transplant; 2007 Jan 15; 7(1):249-55. PubMed ID: 17109733
    [Abstract] [Full Text] [Related]

  • 24. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.
    Chirmule N, Raper SE, Burkly L, Thomas D, Tazelaar J, Hughes JV, Wilson JM.
    J Virol; 2000 Apr 15; 74(7):3345-52. PubMed ID: 10708452
    [Abstract] [Full Text] [Related]

  • 25. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC, Trambley J, Odom K, Anderson DC, Cowan S, Bray R, Lin A, Hollenbaugh D, Aruffo A, Siadak AW, Strobert E, Hennigar R, Larsen CP.
    Transplantation; 2002 Oct 15; 74(7):933-40. PubMed ID: 12394833
    [Abstract] [Full Text] [Related]

  • 26. IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies.
    Baan CC, Boelaars-van Haperen MJ, van Riemsdijk IC, van der Plas AJ, Weimar W.
    Transplant Proc; 2001 May 15; 33(3):2244-6. PubMed ID: 11377516
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.
    Transplantation; 2002 Jun 15; 73(11):1736-42. PubMed ID: 12084995
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up.
    Sheashaa HA, Bakr MA, Fouda MA, El-Dahshan KF, Ismail AM, Sobh MA, Ghoneim MA.
    Int Urol Nephrol; 2007 Jun 15; 39(1):317-9. PubMed ID: 17333530
    [Abstract] [Full Text] [Related]

  • 33. Use of basiliximab and daclizumab in kidney transplantation.
    Olyaei AJ, Thi K, deMattos AM, Bennett WM.
    Prog Transplant; 2001 Mar 15; 11(1):33-7; quiz 38-9. PubMed ID: 11357555
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.